Vemurafenib combined with cytarabine and cladribine results in clinical efficacy but persistent BRAF V600E clone in a newborn affected by high-risk Langerhans cell histiocytosis.
Linda BenefortiAurora ChinniciMaria Luisa ConiglioMaria Rosaria PapaLiana PunziElena SieniCarmela De FuscoPublished in: British journal of haematology (2024)